China Biologic Products Receives Approx. $3.9 Bln Proposal From Investor Group

(RTTNews) - China Biologic Products Holdings, Inc. (CBPO) announced a consortium, composed of David (Xiaoying) Gao, GL Capital Group, Bank of China Group Investment Limited and CDH Investments, has made a non-binding proposal to acquire all of the outstanding common shares of China Biologic Products, that are not already held by the consortium, for $118.00 per share in an all-cash transaction valued at approximately $3.9 billion.

The Consortium stated: "Our compelling proposal benefits all of China Biologic's stakeholders and we want to work collaboratively with the Board to complete a transaction in an efficient and expeditious manner. We also want to partner with the current management team as we take the company forward."